Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-25-002335
Filing Date
2025-08-19
Accepted
2025-08-19 18:45:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10363
  Complete submission text file 0000921895-25-002335.txt   12155
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Subject) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-80718 | Film No.: 251233412
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 138 ATLANTIC AVENUE BROOKLYN NY 11201
Business Address 138 ATLANTIC AVENUE BROOKLYN NY 11201 2122324582
Bandera Partners LLC (Filed by) CIK: 0001399386 (see all company filings)

EIN.: 205269850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A